Home › Prostate Cancer › NCT07209176
Physician- and Patient-based Barriers to NGS Testing
Recruiting
A Clinical Trial to Address Physician- and Patient-based Barriers to NGS Testing
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * men diagnosed with metastatic prostate cancer * seen by Johns Hopkins Medical Oncology as a new patient visit between January 1, 2025 and December 31, 2026 Exclusion Criteria: \- Patients who have already had NGS testing performed.
About the study
The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
What is being tested
- Provider-level and patient education at end of study (other)
- Provider-level and patient-level (other)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Participants: 256 · Started: Jan 6, 2026
Contact the study team
- Catherine Marshall, MD · Phone: 410-955-0231
- Maddie Klugman · Phone: 410-955-8893
Official record on ClinicalTrials.gov — NCT07209176
Locations in the U.S.
| Maryland | Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.